KG Parhofer

3.0k total citations
15 papers, 165 citations indexed

About

KG Parhofer is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, KG Parhofer has authored 15 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in KG Parhofer's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Diabetes Treatment and Management (4 papers). KG Parhofer is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Diabetes Treatment and Management (4 papers). KG Parhofer collaborates with scholars based in Germany. KG Parhofer's co-authors include P. Schwändt, H.C. Geiss, Christoph Otto, Burkhard Göke, Thomas Wibmer, É. Eschwège, Uwe Hasbargen, Andreas W. Flemmer, H.C. Geiss and Hans Vandenberghe and has published in prestigious journals such as European Heart Journal, International Journal of Obesity and Atherosclerosis.

In The Last Decade

KG Parhofer

15 papers receiving 155 citations

Peers

KG Parhofer

PHEOH

EDM

SURGE

PHYSI

Sylvia Asenjo Chile

Luiz Alberto Andreotti Turatti Brazil

João Jácome de Castro Portugal

M. Charlton United Kingdom

Joana Alves Dias Sweden

Maria Wołyniec Poland

Iwona Szydłowska Poland

Laurence J. Dobbie United Kingdom

Marcio José Concepción‐Zavaleta Peru

Pascal M. Mutie Sweden

Sylvia Asenjo Chile

KG Parhofer

67 ×1.1

PHEOH

66 ×1.1

EDM

32 ×0.6

SURGE

19 ×0.6

PHYSI

28 ×1.0

Citations per year, relative to KG Parhofer KG Parhofer (= 1×) peers Sylvia Asenjo

Countries citing papers authored by KG Parhofer

Since Specialization

Citations

This map shows the geographic impact of KG Parhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KG Parhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KG Parhofer more than expected).

Fields of papers citing papers by KG Parhofer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KG Parhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KG Parhofer. The network helps show where KG Parhofer may publish in the future.

Co-authorship network of co-authors of KG Parhofer

This figure shows the co-authorship network connecting the top 25 collaborators of KG Parhofer. A scholar is included among the top collaborators of KG Parhofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KG Parhofer. KG Parhofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Laufs, Ulrich, Uwe Fraass, Bernd Hohenstein, et al.. (2021). Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study. European Heart Journal. 42(Supplement_1). 1 indexed citations

Parhofer, KG, et al.. (2013). Gestational diabetes in Turkmenistan: implementation of a screening program and first results. Archives of Gynecology and Obstetrics. 289(2). 293–298. 9 indexed citations

Dames, Petra, M. Weise, Ramona Puff, et al.. (2012). Suppression of the Nuclear Factor Eny2 Increases Insulin Secretion in Poorly Functioning INS-1E Insulinoma Cells. Experimental Diabetes Research. 2012. 1–8. 5 indexed citations

Parhofer, KG, Clare Bradley, E Eschwège, et al.. (2011). The PANORAMA European study: biomedical and psychological characteristics of people with type 2 diabetes with and without obesity. Acceda (Universidad de Las Palmas de Gran Canaria). 1 indexed citations

Pablos‐Velasco, Pedro de, Caroline Bradley, É. Eschwège, et al.. (2010). The PANORAMA pan-European survey: glycaemic control and treatment patterns in patients with type 2 diabetes. Acceda (Universidad de Las Palmas de Gran Canaria). 6 indexed citations

Bradley, Caroline, É. Eschwège, Pedro de Pablos‐Velasco, et al.. (2010). The PANORAMA pan-European Survey: impact of severe and non-severe hypoglycaemia on quality of life and other patient reported outcomes in patients with type 2 diabetes. Acceda (Universidad de Las Palmas de Gran Canaria). 1 indexed citations

Broedl, Uli C., et al.. (2006). Mo-P6:432 Genetic variants of adipor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels. Atherosclerosis Supplements. 7(3). 141–141. 3 indexed citations

Wibmer, Thomas, et al.. (2005). Novel Mutation (Gly280Ala) in the ATP-Binding Domain of Glycerol Kinase Causes Severe Hyperglycerolemia. Experimental and Clinical Endocrinology & Diabetes. 113(7). 396–403. 6 indexed citations

Parhofer, KG, et al.. (2005). Effect of Pioglitazone on Lipids in Well Controlled Patients with Diabetes Mellitus Type 2 - Results of a Pilot Study. Experimental and Clinical Endocrinology & Diabetes. 113(1). 49–52. 23 indexed citations

10.

Parhofer, KG. (2005). Beyond LDL-Cholesterol: HDL-Cholesterol as a Target for Atherosclerosis Prevention. Experimental and Clinical Endocrinology & Diabetes. 113(8). 414–417. 7 indexed citations

11.

Parhofer, KG, et al.. (2002). Einfluss einer verbesserten Blutzuckereinstellung auf den Lipidspiegel bei Patienten mit Typ-2-Diabetes. DMW - Deutsche Medizinische Wochenschrift. 127(18). 958–962. 4 indexed citations

12.

Geiss, H.C., P. Schwändt, & KG Parhofer. (2002). Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia. Experimental and Clinical Endocrinology & Diabetes. 110(4). 182–187. 21 indexed citations

13.

Parhofer, KG, et al.. (2001). Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent children. International Journal of Obesity. 25(6). 830–837. 69 indexed citations

14.

Parhofer, KG. (1999). Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters. Atherosclerosis. 144(1). 159–166. 7 indexed citations

15.

Fraunberger, Peter, KG Parhofer, Peter Cremer, et al.. (1997). 4.P.255 Lipid and apolipoprotein composition of lipoproteins in hypocholesterolemia of sepsis. Atherosclerosis. 134(1-2). 349–349. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact